ALDH1A3 and cancer: We also considered the possibility that ALDH1A3 was affecting glycolysis indirectly through expression effects on master regulator of glycolytic metabolism, nuclear factor erythroid 2‐related factor 2 (NRF2) [69, 70], which was also shown to be modulator of the hybrid EMT/MET phenotype in cancer cells [10, 71].